Laura Heydmann
Strasbourg, 67000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity.
Journal: Science translational medicine
Published: December 21, 2022
A stable hepatitis D virus-producing cell line for host target and drug discovery.
Journal: Antiviral research
Published: May 13, 2022
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells.
Journal: bioRxiv : the preprint server for biology
Published: March 24, 2021
Hepatitis B virus compartmentalization and single-cell differentiation in hepatocellular carcinoma.
Journal: Life science alliance
Published: January 25, 2021
Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target.
Journal: Gut
Published: November 19, 2020
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery.
Journal: Nature communications
Published: July 16, 2020
A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor.
Journal: Nature communications
Published: June 24, 2019
Interferon-Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection.
Journal: Hepatology (Baltimore, Md.)
Published: November 07, 2018
In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection.
Journal: Antiviral research
Published: August 20, 2018
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development.
Journal: Gastroenterology
Published: August 03, 2018
Last Updated: 09/26/2026